Extendicare Inc. (TSE:EXE – Get Free Report)’s share price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of C$9.43 and traded as high as C$11.03. Extendicare shares last traded at C$10.73, with a volume of 153,937 shares changing hands.
Analyst Upgrades and Downgrades
Several research firms recently commented on EXE. TD Securities lifted their price objective on Extendicare from C$9.50 to C$10.50 and gave the stock a “hold” rating in a report on Thursday, November 14th. BMO Capital Markets set a C$11.00 price objective on shares of Extendicare and gave the company a “market perform” rating in a report on Thursday, January 30th. Finally, Royal Bank of Canada raised their target price on shares of Extendicare from C$9.50 to C$11.00 and gave the stock a “sector perform” rating in a report on Thursday, November 28th.
Get Our Latest Report on Extendicare
Extendicare Price Performance
Extendicare (TSE:EXE – Get Free Report) last announced its earnings results on Tuesday, November 12th. The company reported C$0.19 earnings per share (EPS) for the quarter. Extendicare had a net margin of 4.28% and a return on equity of 60.00%. During the same quarter last year, the business earned $0.13 earnings per share. As a group, equities analysts forecast that Extendicare Inc. will post 0.6134729 earnings per share for the current year.
Extendicare Announces Dividend
The business also recently disclosed a monthly dividend, which will be paid on Friday, February 14th. Stockholders of record on Friday, February 14th will be paid a $0.04 dividend. The ex-dividend date is Friday, January 31st. This represents a $0.48 annualized dividend and a dividend yield of 4.47%. Extendicare’s dividend payout ratio (DPR) is 70.59%.
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Articles
- Five stocks we like better than Extendicare
- Consumer Staples Stocks, Explained
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Health Care Stocks Explained: Why You Might Want to Invest
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.